Loading...
Target Group Inc.
CBDY•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$0.002
$0.00(0.00%)
Target Group Inc. (CBDY) Financial Performance & Statements
Review Target Group Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
77.19%
↑ 77.19%
Operating Income Growth
195.19%
↑ 195.19%
Net Income Growth
149.59%
↑ 149.59%
Operating Cash Flow Growth
466.80%
↑ 466.80%
Operating Margin
28.39%
↑ 28.39%
Gross Margin
57.35%
↑ 57.35%
Net Profit Margin
4.04%
↑ 4.04%
ROE
-5.12%
↓ 5.12%
ROIC
-21.32%
↓ 21.32%
Target Group Inc. (CBDY) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Target Group Inc. stock.
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Cash & Cash Equivalents | $1.87M | $736323.00 | $223843.00 | $113079.00 |
| Short Term Investments | $0.00 | $0.00 | $0.00 | $0.00 |
| Cash & Short Term Investments | $1.87M | $736323.00 | $223843.00 | $113079.00 |
| Net Receivables | $302575.00 | $1.04M | $635940.00 | $318504.00 |
| Inventory | $882279.00 | $1.22M | $0.00 | $99000.00 |
| Other Current Assets | $47260.00 | $106684.00 | $50204.00 | $53639.00 |
| Total Current Assets | $3.10M | $3.09M | $909987.00 | $584222.00 |
| Property Plant & Equipment (Net) | $4.22M | $5.48M | $5.62M | $6.93M |
| Goodwill | $247685.00 | $269460.00 | $263117.00 | $3.68M |
| Intangible Assets | $0.00 | $0.00 | $435.00 | $0.00 |
| Goodwill & Intangible Assets | $247685.00 | $269460.00 | $263117.00 | $3.68M |
| Long Term Investments | $0.00 | $0.00 | $775577.00 | $1.87M |
| Tax Assets | $0.00 | $0.00 | $0.00 | -$1.29M |
| Other Non-Current Assets | $0.00 | $0.00 | -$6.66M | $1.29M |
| Total Non-Current Assets | $4.47M | $5.75M | $6.66M | $12.48M |
| Total Assets | $7.57M | $8.84M | $7.57M | $13.06M |
| Account Payables | $486628.00 | $2.95M | $496398.00 | $2.89M |
| Short Term Debt | $280404.00 | $128464.00 | $111572.00 | $102342.00 |
| Tax Payables | $0.00 | $48581.00 | $35254.00 | $0.00 |
| Deferred Revenue | $0.00 | $43098.00 | $0.00 | $1.05M |
| Other Current Liabilities | $12.47M | $22.89M | $6.28M | $1.06M |
| Total Current Liabilities | $13.10M | $14.59M | $6.93M | $4.04M |
| Long Term Debt | $984691.00 | $1.22M | $1.32M | $1.53M |
| Deferred Revenue Non-Current | $0.00 | $0.00 | $0.00 | $0.00 |
| Deferred Tax Liabilities Non-Current | $0.00 | $0.00 | $0.00 | $0.00 |
| Other Non-Current Liabilities | $42.00 | $355.00 | $5.88M | $9.64M |
| Total Non-Current Liabilities | $984733.00 | $1.22M | $7.20M | $11.17M |
| Capital Lease Obligations | $1.12M | $1.35M | $1.43M | $1.63M |
| Total Liabilities | $14.08M | $15.81M | $14.13M | $15.22M |
| Preferred Stock | $100.00 | $100.00 | $100.00 | $100.00 |
| Common Stock | $61703.00 | $61703.00 | $61703.00 | $61703.00 |
| Retained Earnings | -$30.95M | -$31.11M | -$30.78M | -$26.26M |
| Accumulated Other Comprehensive Income/Loss | -$783724.00 | -$1.09M | -$998829.00 | -$1.11M |
| Total Stockholders Equity | -$6.51M | -$6.97M | -$6.56M | -$2.15M |
| Total Equity | -$6.51M | -$6.97M | -$6.56M | -$2.15M |
| Total Liabilities & Stockholders Equity | $7.57M | $8.84M | $7.57M | $13.06M |
| Total Investments | $0.00 | $0.00 | $775577.00 | $1.87M |
| Total Debt | $1.13M | $1.35M | $1.43M | $1.63M |
| Net Debt | -$743888.00 | $616096.00 | $1.21M | $1.52M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan